Superior Capsular Reconstruction vs. Partial Repair for Rotator Cuff Tears
(SCR Trial)
Trial Summary
What is the purpose of this trial?
Little evidence exists to guide treatment in patients with massive irreparable rotator cuff tears (MRCTS). Arthroscopic partial rotator cuff repair (PRCR) has the longest record of use. The new technique of superior capsular reconstruction (SCR) has more recently been described. Despite high enthusiasm for this technique, its effectiveness, cost and safety profile have not been established. The long-term goal of this study is to perform a multicenter randomized control trial to evaluate the effectiveness of SCR compared to PRCR in patients with MRCTS. The current study is a pilot required to support the development of an expanded formal clinical trial.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Superior Capsular Reconstruction vs. Partial Repair for Rotator Cuff Tears?
Early results suggest that superior capsular reconstruction may help improve pain, range of motion, and function in patients with massive rotator cuff tears. Partial rotator cuff repair has also been shown to improve shoulder movement and can be combined with superior capsular reconstruction for better outcomes.12345
How does the treatment Superior Capsular Reconstruction differ from other treatments for rotator cuff tears?
Superior Capsular Reconstruction (SCR) is a unique surgical treatment for rotator cuff tears that involves using a graft to stabilize the shoulder joint by reconstructing the superior capsule, which is different from traditional rotator cuff repair that focuses on directly repairing the torn tendons. This approach is particularly beneficial for patients with irreparable rotator cuff tears, as it helps restore shoulder function and stability by preventing upward movement of the humeral head.678910
Research Team
Patrick Henry, MD, FRCSC
Principal Investigator
Sunnybrook Health Sciences
Eligibility Criteria
This trial is for individuals who have massive rotator cuff tears larger than 4 cm, involving the supraspinatus and infraspinatus, that haven't improved after at least three months of non-surgical treatment. Participants must be experiencing shoulder pain or weakness but cannot have had previous surgery on the affected shoulder or certain conditions like advanced joint disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either superior capsular reconstruction or partial repair based on randomization
Postoperative Follow-up
Participants are monitored for safety and effectiveness with regular clinic visits
Treatment Details
Interventions
- Partial Repair
- Superior Capsular Reconstruction
Partial Repair is already approved in United States, European Union, Canada for the following indications:
- Massive irreparable rotator cuff tears
- Massive irreparable rotator cuff tears
- Massive irreparable rotator cuff tears
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor
St. Joseph's Healthcare Hamilton
Collaborator
The Ottawa Hospital
Collaborator
Women's College Hospital
Collaborator